BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37940428)

  • 1. Radiomics Model for Predicting FOXP3 Expression Level and Survival in Clear Cell Renal Carcinoma.
    Wang J; Huang Z; Zhou J
    Acad Radiol; 2024 Apr; 31(4):1447-1459. PubMed ID: 37940428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
    He H; Jin Z; Dai J; Wang H; Sun J; Xu D
    Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study.
    Nie P; Yang G; Wang Y; Xu Y; Yan L; Zhang M; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Wang N; Duan S; Wang X; Wang Z
    Eur Radiol; 2023 Dec; 33(12):8858-8868. PubMed ID: 37389608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-based radiomics stratification of tumor grade and TNM stage of clear cell renal cell carcinoma.
    Demirjian NL; Varghese BA; Cen SY; Hwang DH; Aron M; Siddiqui I; Fields BKK; Lei X; Yap FY; Rivas M; Reddy SS; Zahoor H; Liu DH; Desai M; Rhie SK; Gill IS; Duddalwar V
    Eur Radiol; 2022 Apr; 32(4):2552-2563. PubMed ID: 34757449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
    Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X
    J Imaging Inform Med; 2024 Feb; ():. PubMed ID: 38376584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preoperative CT-based deep learning radiomics model in predicting the stage, size, grade and necrosis score and outcome in localized clear cell renal cell carcinoma: A multicenter study.
    Nie P; Liu S; Zhou R; Li X; Zhi K; Wang Y; Dai Z; Zhao L; Wang N; Zhao X; Li X; Cheng N; Wang Y; Chen C; Xu Y; Yang G
    Eur J Radiol; 2023 Sep; 166():111018. PubMed ID: 37562222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma.
    Nie P; Yang G; Wang Z; Yan L; Miao W; Hao D; Wu J; Zhao Y; Gong A; Cui J; Jia Y; Niu H
    Eur Radiol; 2020 Feb; 30(2):1274-1284. PubMed ID: 31506816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.
    Yang G; Nie P; Yan L; Zhang M; Wang Y; Zhao L; Li M; Xie F; Xie H; Li X; Xiang F; Wang N; Cheng N; Zhao X; Wang N; Wang Y; Chen C; Yun C; Cui J; Duan S; Zhang R; Hao D; Wang X; Wang Z; Niu H
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2949-2959. PubMed ID: 35344062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways.
    Zhao Y; Liu G; Sun Q; Zhai G; Wu G; Li ZC
    Eur Radiol; 2021 Jul; 31(7):5032-5040. PubMed ID: 33439312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram.
    Cheng D; Abudikeranmu Y; Tuerdi B
    Curr Med Imaging; 2023; 19(9):1005-1017. PubMed ID: 36411581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma.
    Gao Y; Wang X; Zhao X; Zhu C; Li C; Li J; Wu X
    BMC Cancer; 2023 Oct; 23(1):953. PubMed ID: 37814228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of CT radiomics in predicting the overall survival of patients with stage III clear cell renal carcinoma after radical nephrectomy.
    Han D; Yu N; Yu Y; He T; Duan X
    Radiol Med; 2022 Aug; 127(8):837-847. PubMed ID: 35834111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-Based Radiomics Signature for Preoperative Prediction of Coagulative Necrosis in Clear Cell Renal Cell Carcinoma.
    Xu K; Liu L; Li W; Sun X; Shen T; Pan F; Jiang Y; Guo Y; Ding L; Zhang M
    Korean J Radiol; 2020 Jun; 21(6):670-683. PubMed ID: 32410406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
    Yang Y; Huang H; Liang H
    J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
    Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction models for clear cell renal cell carcinoma ISUP/WHO grade: comparison between CT radiomics and conventional contrast-enhanced CT.
    Han D; Yu Y; Yu N; Dang S; Wu H; Jialiang R; He T
    Br J Radiol; 2020 Oct; 93(1114):20200131. PubMed ID: 32706977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined postoperative nomogram for survival prediction in clear cell renal carcinoma.
    Ming Y; Chen X; Xu J; Zhan H; Zhang J; Ma T; Huang C; Liu Z; Huang Z
    Abdom Radiol (NY); 2022 Jan; 47(1):297-309. PubMed ID: 34647146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
    Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
    Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.